Clinical Study Shows Vapotherm’s New IntellO2™ Module for Precision Flow® System Significantly Improves Maintenance of Premature Neonates in Target Oxygenation Range

EXETER, NH – 2018 – Vapotherm, Inc. today announced the publication of a key prospective, multi-center, controlled, order-randomized crossover trial. The study demonstrates that using the IntellO2 automated oxygen controller module helped clinicians maintain neonates [...]

2018-12-05T22:48:18-05:00Dec 5|Vapotherm Company News|
Go to Top